Crossmark

Correction: Genome-wide CRISPR screen identifies MAD2L1BP and ANAPC15 as targets for brentuximab vedotin sensitivity in CD30+ peripheral T-cell lymphoma

Crossref DOI link: https://doi.org/10.1038/s41375-025-02811-3

Published Online: 2025-11-10

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Suto, Keito https://orcid.org/0000-0001-8212-5664
Takei, Norio

Yokoyama, Keito

Chiba, Masahiro https://orcid.org/0000-0003-2731-6091
Ishio, Takashi

Maeda, Michiyuki

Goto, Hideki

Endo, Tomoyuki

Teshima, Takanori https://orcid.org/0000-0002-0941-271X
Yang, Yibin https://orcid.org/0000-0002-9948-8696
Nakagawa, Masao https://orcid.org/0000-0002-8602-6054
License Information

Text and Data Mining valid from 2025-11-10

Version of Record valid from 2025-11-10
More Information

Article History

First Online: 10 November 2025

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below